The latest work of AlphaMol, which is entitled "Computational drug development for membrane protein targets", has been published in Nature Biotechnology (doi:10.1038/s41587-023-01987-2).

The application of computational biology in drug development for membrane protein targets has experienced a boost from recent developments in deep learning-driven structure prediction, increased speed and resolution of structure elucidation, machine learning structure-based design and the evaluation of big data. In this work, we analyzed and discussed how to apply computational methods to accelerate membrane protein, including GPCR, drug discovery.

Read it online from here:
https://doi.org/10.1038/s41587-023-01987-2

Congratulations to all contributors.

AlphaMol is hiring joint PhD candidates with Prof. Elise Dumont from the Centre national de la recherche scientifique (CNRS) in France. The topic of this position would be developing and applying computational methods to (1) illuminating GPCR biological mechanism at the atomic level; and (2) GPCR drug discovery.
All applicants should be submitted to the following emails: elise.dumont'@'univ-cotedazur.fr, info'@'alphamol.com